Skip to main content

Association of CYP2R1 and CYP27B1 genes with the risk of obesity and vitamin D metabolism in Saudi women



Epigenome, genetic variants, and other environmental factors involved in gene regulation are highly inter-dependent in several chronic diseases, including obesity, cardiovascular disease, and diabetes. The present study aimed at testing the associations and the mechanism involved in silencing of CYP2R1 gene in normal and obese Saudi women patients. Height, weight, BMI, 25-hydroxy vitamin D, parathyroid hormone, glycemic status, and lipid profile (TG, LDL, HDL, and TC) of CYP2R1 were measured in 100 women (31 normal and 69 obese patients).


Our result shows that hypermethylation in site 2 of the CYP2R1 gene with body weight (p < 0.004), BMI (p < 0.002), waist circumference (p < 0.002), total-LDL (p < 0.027), total cholesterol (p < 0.022), and vitamin D (VD) (close to borderline significance p < 0.06) and site 4 of CYP2R1 with LDL (p < 0.041) in the four tested sites among normal and obese women was significantly associated. Moreover, we tested five different CpG sites in the CYP27B1 gene where site 5 correlated significantly with VD levels.


Our present study clearly indicates that hypermethylation of specific sites in the CYP2R1 and CYP27B1 genes might regulate gene expression with special reference to the risk of obesity and vitamin D metabolism.


Obesity-associated noncommunicable diseases are complex, multifactorial diseases that are a big challenge in the treatment and management. These diseases have great impacts on the economies of the developed and developing countries. WHO reported that 2.8 million people die each year due to obesity and its associated noncommunicable diseases [29]. The prevalence of obesity cases is exponential in Saudi Arabia for the past few decades [19]. Obesity may occur due to several causative factors including unhealthy food habits, sedentary lifestyles, and genetic and environmental factors. Recent evidence from nutrigenetics and nutrigenomics data has alarmed that the susceptible gene networks are complex and are key players in obesity-linked noncommunicable diseases. Deriving from these data, gene regulation in chronic diseases is highly complex. Specifically, epigenome, genetic variants, and other environmental factors involved in gene regulation are highly inter-dependent. More specifically, genome-wide methylation data analysis clearly indicated that epigenome plays a crucial role in gene regulation [26].

Different meta-analyses clearly indicated that vitamin D deficiency is strongly linked with obesity, diabetes, and cardiovascular diseases [25, 27]. In obesity and vitamin D metabolism-related gene networks, vitamin D receptor (VDR), cytochrome P450 gene family, i.e., CYP2R1, CYP24A1, and CYP27B1, are key players in vitamin D metabolism and interconnected with energy balance, adipocyte physiology, and adipokine secretion. Approximately, 200 genes participate in the pathophysiology of obesity [25, 32]. The gene regulations are still unclear with SNP, microRNA, and epigenomic level [14]. Especially, DNA methylation sites in the promotor region inhibit the binding of specific transcription factors which cause downregulation of specific genes.

Commonly, DNA methylation and genetic variants are linked with downregulation of gene expression. For example, in vivo studies revealed that gene expression of CYP2R1, CYP27A1, CYP27B1, and vitamin D receptor is downregulated due to hyper–methylation in CpG sites [7, 21]. SNPs in CYP2R1 and CYP27B1 genes are strongly associated with abnormal vitamin D metabolism and linked to various pathophysiological conditions [22, 23, 30, 28, 32]. In another study, hypermethylation in the CpG islands of both CYP2R1 and CYP27B genes is susceptible to negative gene regulation [9]. Consequently, epigenetic alterations such as hypermethylation in CYP2R1 and CYP27B1 genes are reported to interfere in the metabolic pathway and decrease vitamin D levels, thereby contributing to genesis of obesity-linked diseases [1]. Gene-specific hypermethylation in the CYP2R1, CYP27B1, and VDR genes was observed in the obesity-induced mice [21].

Parathyroid hormone (PTH) is directly involved in calcium homeostasis. A few studies have indicated that aberrant methylation patterns downregulate CYP2R1, CYP27B1, and VDR genes which are involved in the PTH-dependent calcium metabolism [13]. Besides, CYP2R1 and CYP27B1 are implicated in altered lipid profiles. Mice fed a high-fat diet demonstrated decreased CYP2R1 and CYP27B1 expression [5]. Specifically, CYP2R1 is downregulated in the extrahepatic and liver tissues in the obesity-induced mice model which causes vitamin D deficiency [8]. Likewise, mice fed a high-fat diet evidenced decrease of vitamin D deficiency, whereas expression of CYP1R1, CYP24A1, and CYP27B1 negatively altered lipid profile and increased lipogenesis [6]. Globally, a few meta-analyses have clearly indicated the association between VD metabolism and obesity in different ethnic populations. However, there is no epigenetic data on obesity-related traits and VD metabolism genes in Saudi populations. Therefore, the present study was undertaken to find the correlation of methylation patterns with CYP1R1 and CYP27B1 genes between normal and obese Saudi women.



The experimental population was 100 Saudi adult females (18 to 60 years) who were selected randomly wherein 31 got assigned to normal weight group [body mass index (BMI; in kg/m2) ≤ 25] and 69 patients were assigned the obese group [body mass index (BMI; in kg/m2) > 30]. Care was taken to ensure that the patients were not diagnosed with chronic diseases and attended fitness clubs in different areas (north, east, west, and central area) within Riyadh city. Informed consent was obtained from all patients. The study was approved by King Saud University, Saudi Arabia (reference no.: E-19–4028). The study is in concurrence with the policy of the College of Food and Agriculture Sciences Research Centre and within the ethical boundaries of Declaration of Helsinki.

Anthropometric measurements

Anthropometric parameters such as weight, height, body mass index (BMI), and waist circumference were measured according to our previous report [2].

Biochemical assessments

Intravenous blood samples were collected after overnight fasting. A part of the blood sample was centrifuged after coagulation, and serum was used for routine biochemical analysis. Another portion of the blood sample was transferred to a heparinized tube for methylation studies and stored at − 80 °C until assays were performed. Biochemical parameters such as fasting serum levels of lipids profile (TG, LDL, HDL, and TC) were measured using an automated chemical analyzer (UDICHEM-300, USA) according to the reference protocols — UI59L, UI41HD, UI 24, etc. Vitamin D and PTH were measured using the cobas e602 analyzer (Roche Diagnostics, Indianapolis, IN, USA).

DNA methylation analyses by pyrosequencing method

Genomic DNA was isolated from whole blood samples using the Gentra Puregene Blood Kit (Qiagen, Valencia, CA, USA). Purified genomic DNA sample was then bisulfite converted using an EpiTect Bisulfite Kit (Qiagen, USA). Once treated, NaBis-DNA was amplified using PyroMark PCR Kit (Qiagen, USA) with specific primers of CYP2R1 and CYP27B1. DNA methylation levels at CpG sites were assessed using pyrosequencing (PyroMark Q24, Qiagen). All the steps in pyrosequencing assay were practiced according to the manufacturer’s instructions.

Statistical analysis

Statistical analysis was carried out using the GraphPad Prism 9 software (GraphPad Software, CA, USA) and Microsoft Excel 2007 (Microsoft Corporation, USA). The variables were presented as mean ± standard deviation (SD). Group comparisons were conducted using an independent Student’s t-test and Mann–Whitney U-test for variables not normally distributed. Correlation between various variables was calculated using Spearman rank correlation coefficient (R) with graphical representations designed using linear regression. The p-value was considered significant if less than 0.05.


In the present study, we analyzed the CYP2R1 and CYP27B1 methylation patterns and their associations with anthropometric parameters, lipid profiles, and vitamin D levels in Saudi obese women. The pyrogram of CYP27B1 and CYP2R1 genes were indicate different CpG sites (Fig. 1 A & B). The box plots show means methylation percentage between samples from normal and obese women for the CYP27B1 and four CpG sites of CYP2R1 genes (Fig. 2). The inside of each box represents the median, and the lower and upper edges of the boxes represent 5 to 45% methylation. The upper and lower lines outside the boxes represent the minimum and maximum values (error bars). Overall, a comparison of different sites of CYP2R1 and CYP27B1 genes of normal vs obese women indicates that there was little change in respect of methylation in obese women compared to the nonobese controls except at site 2 of CYP2R1, i.e., DNA methylation at site 2 of CYP2R1 gene is statistically significant (p < 0.001 — Mann–Whitney Test) (Table 1; Fig. 3), and DNA methylation of CYP27B1 gene is not statistically significant. (Supplementary data Table S1 and Figs. S1–S7). Overall, methylation of CpG sites in CYP2R1 and CYP27B1 was analyzed in regard to anthropometric and biochemical parameters. In Spearman correlation analysis, anthropometric parameters such as weight, BMI, waist circunference, plasma, and biochemical parameters, viz., TG, TC, LDL, HDL, VD, and PTH levels, showed a weak negative and positive correlation with CYP2R1 and CYP27B1. As shown in Tables 2 and 3, a positive correlation with site 2 of CYP2R1 with weight (p < 0.004), BMI (p < 0.002), waist circumference (p < 0.002), TC (p < 0.022), and LDL (p < 0.027) and site 4 with LDL (p < 0.041) was significantly correlated (Table 2). CYP27B1 methylation status was not significantly related to anthropometric and biochemical parameters except site 5 with VD (p < 0.047) (Table 3).

Fig. 1
figure 1

Pyrogram of CYP2R1 methylation sites 1 to 4 (A) and pyrogram of CYP27B1 methylation sites 1 to 5 (B)

Fig. 2
figure 2

Box plot of median DNA methylation of 5 CpG sites within the promoter of CYP27B1 and 4 CpG site of CYP2R1 genes

Table 1 Comparison between total promoter methylation of CYP2R1 of normal and obese samples
Fig. 3
figure 3

Comparison between total promoter methylation of CYP2R1 of normal and obese samples

Table 2 Spearman correlation between sites of CYP2R1 methylation with different anthropometric and biochemical parameters
Table 3 Spearman correlations between sites of CYP27B1 methylation with different anthropometric and biochemical parameters

These data indicate the direct and/or indirect role of CYP2R1 and CYP27B1 in obesity patients in this study. Spearman’s correlation coefficient clearly reveals a significant correlation between hypermethylation CpG sites of CYP2R1 and BMI, body weight, waist circumference, TC, LDL, and VD (at close to borderline significance p > 0.06) of obese patients (Figs. 4 and 5). However, no significant association of methylation of the five different sites in CYP27B1 with the lipid profiles was noticed. Also, the evidence from the best fit line curve of Spearman’s correlation coefficient graph indicates that the hypermethylation in the CpG site 5 of CYP27B1 significantly correlates with deficiency of vitamin D levels (Fig. 6). This is an important implication that CYP2R1 and CYP27B1 are crucial role players of vitamin D metabolism and pathophysiological mechanisms of obesity.

Fig. 4
figure 4

Spearman correlations between site 2 of CYP2R1 methylations with different anthropometric and biochemical parameters

Fig. 5
figure 5

Spearman correlations between site 4 of CYP2R1 methylations with different anthropometric and biochemical parameters

Fig. 6
figure 6

Spearman correlations between site 5 of CYP27B1 methylations with different anthropometric and biochemical parameters


Epigenetic changes have been associated with the development of several chronic diseases including obesity and cancer [10, 20]. Analysis of methylation at the level of DNA provides information about gene regulation and identifies the potential markers of such chronic diseases [12]. Studies reported that irregular gene expression patterns due to epigenetic alterations and functions of VDR, CYP2R1, and CYP27B1 lead to specific target-associated pathophysiological conditions [1, 9]. Several reports have shown that epigenetic changes are associated with induction of obesity and alteration of vitamin D metabolism by altering the expression of crucial genes such as VDR, CYP2R1, and CYP27B1 and thereby influence the VD-associated metabolites and abnormal homeostasis of lipid profile [3, 21]. Our previous study [2] also clearly revealed that VDR methylation and SNPs influence the expression of CYP2R1 and CYP27B1 genes.

CYP2R1 and CYP27B1 genes are members of P450 superfamily enzymes which are directly involved in vitamin D metabolic pathways and also indirectly regulate synthesis of cholesterol, steroid, and various lipids [15, 18, 16]. Previous studies have expounded the importance of vitamin D in adipose physiology. Particularly, CYP2R1 and CYP27B1 genes are involved in adipose tissue homeostasis [11]. Taken together, these results indicate a positive correlation between obese and nonobese individuals, and that CYP2R1 and CYP27B1 genes are involved in lipid metabolism. Moreover, these data are consistent with our previous research wherein epigenetic changes and SNPs in the VDR gene have a strong correlation with anthropometric parameters such as body weight, BMI, waist circumference, and lipid profile in obese patients [2]. Bakos et al. [4] have reported that SNPs in CYP2R1 gene are strongly associated with severely vitamin D-deficient individuals. In another study, mutated CYP2R1 gene has been shown as linked to obesity and type 2 diabetes mellitus [31]. In a meta-analysis study, CYP2R1 and CYP27B1 genes were shown linked with different anthropometric measures of obesity and vitamin D deficiency patients [17]. In a similar study, CYP2R1 gene variants are shown as connected to BMI and body weight [7]. In a Finnish study, genetic variants of CYP2R1 gene were linked to total and LDL cholesterols [24], which confirms the findings in our study.


The objective of this study was to determine the association between obesity and methylation of vitamin D-dependent genes (i.e., CYP2R1 and CYP27B1). Vitamin D-specific downstream targets with risk of obesity-related parameters including height, weight, BMI, 25-hydroxyvitamin D, parathyroid hormone, glycemic status, and lipid profile (TG, LDL, HDL, and TC) have provided strong clues to clarify the molecular mechanisms. These genes underlie the pathogenesis of vitamin D-associated diseases and may have potential application in the clinical diagnosis and treatment of obesity-linked diseases in the future.


  1. Acs O, Peterfia B, Hollosi P, Luczay A, Torok D, Szabo A (2017) Methylation status of CYP27B1 and IGF2 correlate to BMI SDS in children with obesity. Obes Facts 10(4):353–362

    Article  Google Scholar 

  2. AlSedairy SA, Binobead MA, Al-Harbi LN, Syed NA, Subbarayan PV, Arzoo S, Alshatwi AA (2020) Association between vitamin D receptor methylation with vitamin D, parathyroid hormone levels and lipid profile in normal and obese Saudi Females. Progr Nutr 22(4):e2020085

    Google Scholar 

  3. Bahrami A, Sadeghnia HR, Tabatabaeizadeh SA, Bahrami-Taghanaki H, Behboodi N, Esmaeili H, Ferns GA, Mobarhan MG, Avan A (2018) Genetic and epigenetic factors influencing vitamin D status. J Cell Physiol 233(5):4033–4043

    Article  Google Scholar 

  4. Bakos B, Szili B, Szabo B, Horvath P, Kirschner G, Kosa JP, Toldy E, Lakatos P, Tabak AG, Takács I (2020) Genetic variants of VDR and CYP2R1 affect BMI independently of serum vitamin D concentrations. BMC Med Genet 21:129

    Article  Google Scholar 

  5. Bonnet L, Karkeni E, Couturier C, Astier J, Defoort C, Svilar L, Tourniaire F, Mounien L, Landrier JF (2021) Four days high fat diet modulates vitamin D metabolite levels and enzymes in mice. J Endocrinol 248(1):87–93

    Article  Google Scholar 

  6. Borges CC, Salles AF, Bringhenti I, Mandarim-DE-Lacerda CA, Aguila MB (2018) Vitamin D deficiency increases lipogenesis and reduces beta-oxidation in the liver of diet-induced obese mice. J Nutr Sci Vitaminol (Tokyo) 64(2):106–115

    Article  Google Scholar 

  7. Dorjgochoo T, Shi J, Gao YT, Long J, Delahanty R, Xiang YB, Cai Q, Shu XO (2012) Genetic variants in vitamin D metabolism-related genes and body mass index: analysis of genome-wide scan data of approximately 7000 Chinese women. Int J Obes (Lond) 36(9):1252–1255

    Article  Google Scholar 

  8. Elkhwanky MS, Kummu O, Piltonen TT, Laru J, Morin-Papunen L, Mutikainen M, Tavi P, Hakkola J (2020) Obesity represses CYP2R1, the vitamin D 25-hydroxylase, in the liver and extrahepatic tissues. JBMR Plus 4(11):e10397

    Article  Google Scholar 

  9. Fetahu IS, Hobaus J, Kallay E (2014) Vitamin D and the epigenome. Front Physiol 5:164

    Article  Google Scholar 

  10. Gao Q, Tang J, Chen J, Jiang L, Zhu X, Xu Z (2014) Epigenetic code and potential epigenetic-based therapies against chronic diseases in developmental origins. Drug Discovery Today 19(11):1744–1750

    Article  Google Scholar 

  11. Jeong M, Chan YP, Sung NH (2015) High fat diet-induced obesity alters vitamin D metabolizing enzyme expression in mice. BioFactors 41(3):175–182

    Article  Google Scholar 

  12. Jin Z, Liu Y (2018) DNA methylation in human diseases. Genes Dis 5(1):1–8

    Article  MathSciNet  Google Scholar 

  13. Klahold E, Penna-Martinez M, Bruns F, Seidl C, Wicker S, Badenhoop K (2020) Vitamin D in type 2 diabetes: genetic susceptibility and the response to supplementation. Horm Metab Res 52(7):492–499

    Article  Google Scholar 

  14. Li-ning S, Yan-bing W, Chun-guang W, Hui-ping W (2017) Network analysis identifies common genes associated with obesity in six obesity-related diseases. J. Zhejiang Univ. Sci. B 18(8):727–732

  15. Mahmoud SE, Outi K, Terhi TP, Johanna L, Laure MP, Maija M, Pasi T, Jukka H (2020) Obesity represses CYP2R1, the vitamin D 25-hydroxylase, in the liver and extrahepatic tissues. JBMR Plus 4(11):e10397

    Google Scholar 

  16. Mazahery H, von Hurst PR (2015) Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients 7(7):5111–5142

    Article  Google Scholar 

  17. Minxian W, Ru Z, Min W, Liuxin Z, Yajie D, Zongzhe T, Hongliang W, Wei Z, Yue C, Jie W (2021) Genetic polymorphism of vitamin D family genes CYP2R1, CYP24A1, and CYP27B1 are associated with a high risk of non-alcoholic fatty liver disease: a case-control study. Front Genet 12:717533

    Article  Google Scholar 

  18. Nelson DR (2002) Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution. Arch Biochem Biophys 409(1):18–24

    Article  Google Scholar 

  19. Nora AA, Mada HB, Norah A, Mohammed FA, Rasha AA, Nasser FB, Zaied A, Saleh AA (2021) Obesity in Saudi Arabia in 2020: prevalence, distribution, and its current association with various health conditions. Healthcare (Basel) 9(3):311

    Google Scholar 

  20. Obrien KM, Sandler DP, Xu Z, Kinyamu HK, Taylor JA, Weinberg CR (2018) Vitamin D, DNA methylation, and breast cancer. Breast Cancer Res 20(1):70

    Article  Google Scholar 

  21. Parsanathan R, Jain SK (2019) Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high-fat diet-fed obese mice. Sci Rep 9:14784

    Article  Google Scholar 

  22. Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, Parra-Rojas I, de la Cruz-Mosso U (2020) Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci 21(24):9626

    Article  Google Scholar 

  23. Sadeghi H, Kamaliyan Z, Mohseni R, Sahebi U, Nazemalhosseini-Mojarad E, Aghaei N, Zali MR, AsadzadehAghdaei H, Mirfakhraie R, Moshiri A (2021) Dysregulation of vitamin D synthesis pathway genes in colorectal cancer: a case-control study. J Clin Lab Anal 35(2):e23617

    Article  Google Scholar 

  24. Soininen S, Eloranta AM, Viitasalo A, Dion G, Erkkila A, Sidoroff V, Lindi V, Mahonen A, Lakka TA (2018) Serum 25-hydroxyvitamin D, plasma lipids, and associated gene variants in prepubertal children. J Clin Endocrinol Metab 103(7):2670–2679

    Article  Google Scholar 

  25. Suderman M, Stene LC, Bohlin J, Page CM, Holvik K, Parr CL, Magnus MC, Haberg SE, Joubert BR, Wu MC et al (2016) 25-Hydroxyvitamin D in pregnancy and genome wide cord blood DNA methylation in two pregnancy cohorts (MoBa and ALSPAC). J Steroid Biochem Mol Biol 159:102–109

    Article  Google Scholar 

  26. van Dijk SJ, Molloy PL, Varinli H, Morrison JL, Muhlhausler BS, members of EpiSCOPE. (2015) Epigenetics and human obesity. Int J Obes (Lond) 39:85–97

    Article  Google Scholar 

  27. Vimaleswaran KS, Cavadino A, Berry DJ, Whittaker JC, Power C, Jarvelin MR, Hypponen E (2013) Genetic association analysis of vitamin D pathway with obesity traits. Int J Obes (Lond) 37(10):1399–1406

    Article  Google Scholar 

  28. Wang M, Kong W, He B, Li Z, Song H, Shi P, Wang J (2018) Vitamin D and the promoter methylation of its metabolic pathway genes in association with the risk and prognosis of tuberculosis. Clin Epigenetics 10(1):118

    Article  Google Scholar 

  29. WHO (2021) Obesity. World Health Organization.

  30. Zhang TP, Chen SS, Zhang GY, Shi SJ, Wei L, Li HM (2021) Association of vitamin D pathway genes polymorphisms with pulmonary tuberculosis susceptibility in a Chinese population. Genes Nutr 16:6

    Article  Google Scholar 

  31. Zhao Y, Wang G, Li Y, Liu X, Liu L, Yang K, Wang C, Wei S (2020) Evaluation of the associations of GC and CYP2R1 genes and gene-obesity interactions with type 2 diabetes risk in a Chinese rural population. Ann Nutr Metab 76:175–182

    Article  Google Scholar 

  32. Zhou Y, Zhao LJ, Xu X, Ye A, Travers-Gustafson D, Zhou B, Wang HW, Zhang W, Lee Hamm L, Deng HW et al (2014) DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation. J Steroid Biochem Mol Biol 144(Pt A):207–214

    Article  Google Scholar 

Download references


The authors would like to acknowledge the financial support provided by the Researchers Supporting Project number (RSP2023R178), King Saud University, Riyadh, Saudi Arabia.


The authors would like to acknowledge the financial support provided by the Researchers Supporting Project number (RSP2023R178), King Saud University, Riyadh, Saudi Arabia.

Author information

Authors and Affiliations



SAA, MAB, and AAA designed the research; SAA, AAA, PVS, and JA conducted the research; SAA, DSA, LNA, and GS analyzed the data and wrote the manuscript; SA, LNA, and MAB revised and proofread the manuscript; and SAA, GS, and LNA hold the primary responsibility for the final content of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Vaiyapuri Subbarayan Periasamy.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Comparison between total promoter methylation of CYP27B1 of normal and obese samples. Fig. S1 Comparison between total promoter methylation of CYP27B1 of normal and obese samples. Fig. S2. Spearman Correlations between site 1 of CYP2R1 methylations with different anthropometric and biochemical parameters. Fig. S3. Spearman Correlations between site 3 of CYP2R1 methylations with different anthropometric and biochemical parameters. Fig. S4. Spearman Correlations between site 1 of CYP27B1 methylations with different anthropometric and biochemical parameters. Fig. S5. Spearman Correlations between site 2 of CYP27B1 methylations with different anthropometric and biochemical parameters. Fig. S6. Spearman Correlations between site 3 of CYP27B1 methylations with different anthropometric and biochemical parameters. Fig. S7. Spearman Correlations between site 4 of CYP27B1 methylations with different anthropometric and biochemical parameters.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AlSedairy, S.A., Al-Harbi, L.N., Binobead, M.A. et al. Association of CYP2R1 and CYP27B1 genes with the risk of obesity and vitamin D metabolism in Saudi women. J Genet Eng Biotechnol 21, 59 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Vitamin D
  • Obesity
  • Genetic variants
  • Genes
  • BMI
  • Saudi